Patents
Patents for C07C 327 - Thiocarboxylic acids (5,460)
01/2009
01/06/2009CA2169219C Substituted benzenesulfonylureas and -thioureas, processes for their preparation, their use for the production of pharmaceutical preparations, and pharmaceutical preparations containing them
01/01/2009US20090005594 Z=reacting Z-C(O) CH2 C(O)-Z ( Z= Cl)or HO C(O) CH2 (CO) OH and a carboxylic acid activating agent e.g. dicyclohexyl carbodiimide with a thiohydrazide compound ; enhances the desirable tumor attacking properties of anticancer agents without further increasing undesirable side-effects
12/2008
12/31/2008EP1149075B1 Synthesis of dithioester chain transfer agents
12/30/2008US7470810 Such as 1-dodecane-thiotrifluoroacetate; alkyl/arylthiol is treated with trifluoroacetic anhydride in presence of pyridine, solvent (dichloromethane), and dimethylaminopyridine (DMAP) as catalyst; for protection of amino acids
12/30/2008US7470722 For treating disease, such as cancer, neurological disorders, including polyglutamine-repeat disorders, anemias, thalassemias, inflammatory conditions, autoimmune diseases and cardiovascular conditions
12/30/2008US7470646 Lewis acid Cu, Zn, Fe, Sc metal compound is confined in a crosslinked copolymer of styrene and 2-[2-phenyl allyloxy] methyl] oxylan; recoverable; as a catalyst in aldol reactions, cyanation, allylation, Michael reactions, Mannich reactions, Diels Alder reactions and Friedel Crafts reactions
12/25/2008US20080319080 Amide Compounds and Their Use
12/25/2008US20080318915 Deuterium-enriched fluticasone propionate
12/17/2008EP2001840A1 Associations of xanthogenates and cyclodextrins, and their use
12/17/2008EP2001839A1 Improvements in the preparation of intermediates leading to [4-(5-aminomethyl-2-fluoro-phenyl)-piperidin-1-yl]-(4-bromo-3-methyl-5-propoxy-thiophen-2yl)-methanone hydrochloride
12/16/2008US7465803 Nitroderivatives as drugs for diseases having an inflammatory basis
12/11/2008WO2008149962A1 Thioimidate compound and use thereof for controlling pests
12/11/2008US20080306281 Novel compounds comprising a thiocarbonyl-sulfanyl group which can be used for the radical synthesis of alpha-perfluoroalkylamine compounds
12/10/2008EP1999133A2 Process for preparation of hiv protease inhibitors
12/04/2008WO2008067338A3 Biosynthetic pathway and genes required for tropodithietic acid biosynthesis in silicibacter tm1040
12/04/2008US20080300249 tyrosine kinase inhibitors such as 5-(3,3-Dimethyl-ureido)-3-heptyloxy-isothiazole-4-carboxylic acid amide, used for treating hyperproliferative disorders in mammals; anticarcinogenic agents; antiproliferative agents
12/03/2008EP1997555A1 Immobilized lewis acid catalysts coated with ionic liquids and use thereof
12/03/2008CN100439321C Terpinene-4-ol derivative and its use
11/2008
11/27/2008WO2008024303A3 Compounds for treating proliferative disorders
11/27/2008WO2008011561A3 End-modified poly(beta-amino esters) and uses thereof
11/27/2008US20080293137 Compounds that abrogate dna damage induced cell cycle g2 checkpoint and/or augment anti-cancer activity of dna-damaging treatments
11/26/2008CN101312944A Organic sulfur compounds and use thereof as arthropodicides
11/18/2008CA2133587C Compounds having selectivity for retinoid x receptors
11/13/2008US20080281140 Method and Device for Completely Hydrogenating a Hydrocarbon Flow
11/12/2008CN101302177A Phenolic compound and recording material containing the same
11/06/2008US20080275010 Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs
11/05/2008EP1986995A1 Process for preparing 3, 4-disubstituted phenylacetic acids and novel intermediates
11/05/2008EP1986631A2 Methoxypolyethylene glycol thioester chelate and uses thereof
11/05/2008CN100430345C Method for producing compounds having CF2O bridge
10/2008
10/30/2008WO2008130571A1 Nuclear receptor binding agents
10/30/2008US20080269496 Catalytic system of asymmetric reactions in aqueous media; react a silicon enolate and formaldehyde; catalyst obtained by mixing chiral ligands with scandium triflate
10/30/2008US20080269340 BIS (thio-hydrazide amide) salts for treatment of cancers
10/21/2008US7439266 Malononitrile compound and use thereof
10/21/2008CA2331408C Fatty analogues for the treatment of obesity, hypertension and fatty liver
10/16/2008WO2008024302A3 Compounds for treating proliferative disorders
10/14/2008US7435843 Thiobenzoic acid, N-malonylhydrazide in which the free carboxy group is protected; enhances the desirable tumor attacking properties of anticancer agents without further increasing undesirable side-effects
10/14/2008CA2331395C Fatty acid analogues for the treatment of diabetes
10/07/2008CA2362831C Thioamide derivatives
10/02/2008US20080242702 Paclitaxel enhancer compound
09/2008
09/30/2008US7429618 substituted triarylmethane compounds for immunosuppressive treatment of autoimmune disorders or inflammatory diseases; [Tris-(4-fluoro-phenyl)-methyl]-phosphonic acid dimethyl ester; Gardos channel antagonists
09/30/2008CA2381001C Carbamate derivative and agricultural/horticultural fungicide
09/24/2008CN101270069A Synthesis of taxol enhancers
09/23/2008US7427394 Delivering labile agents; buffering effect; transfecting nucleic acids; nontoxic
09/23/2008CA2283643C Certain cyclic thio substituted acylaminoacid amide derivatives
09/18/2008US20080227827 Compounds that abrogate dna damage induced cell cycle g2 checkpoint and/or augment anti-cancer activity of dna-damaging treatments
09/12/2008WO2008108735A1 2 -substituted- 3 -phenylpropionic acid derivatives and their use in the treatment of inflammatory bowel disease
09/12/2008CA2679314A1 New compounds
09/09/2008US7423161 Dithiocarboxylates, dithiocarbonates and trithiocarbonates in which the ester group is 1-substituted with a hydroxy, ether, amine or halo group, e.g., 1-(N-acetylamino)-2,2,2-trifluoroethyl]-O-ethyl dithiocarbonate and 1-ethoxythiocarbonylsulphanyl-2,2,2-trifluoro-ethyl ester of benzoic acid
09/04/2008US20080214655 Paclitaxel or a paclitaxel analog and 2,5-Dimethoxythiobenzoic acid N-methylhydrazine; antitumor; nontoxic
09/02/2008US7419933 chiral zirconium catalyst that can maintain its high catalytic activity even after long-term storage, which is stable in air and storable for a long period of time, and recoverable and reusable after reaction, is provided.
09/02/2008CA2169696C Substituted benzenesulfonylureas and -thioureas, processes for their preparation and use of pharmaceutical preparations based on these compounds, and medicaments containing them
08/2008
08/27/2008CN100413845C Compounds for modulating cell proliferation
08/14/2008WO2008096509A1 Polymerizable optically-active compound, and polymerizable composition comprising the polymerizable optically-active compound
08/14/2008US20080194681 Novel Inhibitors of Histone Deacetylase for the Treatment of Disease
08/14/2008US20080194651 Nitroderivatives as drugs for diseases having an inflammatory basis
08/13/2008EP1956025A1 Aqueous catalytic process for the preparation of thiocarboxylate silane
08/13/2008CN101239936A Antineoplastic sulfur-containing alkannin and naphthoquinones derivatives
08/06/2008EP1951664A1 Organic sulfur compounds and use thereof as arthropodicides
08/06/2008CN101238137A Derivatives of 4-or 5-aminosalicylic acid
08/05/2008US7407985 Compounds that abrogate DNA damage induced cell cycle G2 checkpoint and/or augment anti-cancer activity of DNA-damaging treatments
08/05/2008CA2337098C Anthranilic acid derivatives
07/2008
07/29/2008US7405218 Isothiazole derivatives useful as anticancer agents
07/23/2008CN100404502C Process for enantioselective synthesis of single enantiomers of modafinil by asymmetric oxidation
07/22/2008US7402690 Chain transfer agents for raft polymerization in aqueous media
07/16/2008CN101223133A Synthesis of bis(thio-hydrazide amide) salts
07/09/2008EP1940787A1 Novel ido inhibitors and methods of use thereof
07/09/2008EP1940779A2 Amide compounds and their use
07/09/2008EP1465863B1 Potassium channel modulators
07/09/2008CN101218201A Benzoic acid derivatives that are modulators or antagonists of GlyR
07/08/2008US7396844 3-(4-amidinobenzoylamino)-4-[5-amidino-2-(2-carboxy-2-oxoethyl)phenoxy]butanoic acid; anticoagulant; blood coagulation factor X and thrombin inhibitor; cerebral infarction, thrombosis, embolism, transient ischemic attack (TIA) and subarachnoidal hemorrhage (vasospasm); ischemic heart diseases
07/08/2008CA2211939C Process for producing rhein and diacerhein
07/03/2008WO2008077170A2 Benzothioamides, and use thereof for relaxing smooth muscles
07/03/2008US20080161597 Reacting ketene with hydrogen sulphide in the presence of a nitrogenous base or reacting ketene with an aqueous alkali metal hydrogen sulphide solution; one pot process; used to produce drugs
07/02/2008CN100398516C Synthesis of taxol enhancers
06/2008
06/26/2008WO2008074677A1 Process for preparing 1- (2-ethyl-butyl) -cyclohexanecarboxylic acid
06/26/2008CA2672505A1 Process for preparing 1-(2-ethyl-butyl)-cyclohexanecarboxylic acid
06/17/2008US7388098 Dynamic resolution of isomers and resolved isomers
06/17/2008US7388028 Methoxypolyethylene glycol thioester chelate and uses thereof
06/12/2008WO2008068751A1 Novel protein kinase modulators and therapeutic uses thereof
06/12/2008WO2008067713A1 Compounds having substituted cyclopentane structure, their preparation methods and medical uses
06/12/2008US20080139836 Polymerization with living characteristics
06/12/2008US20080139764 Polymerization with living characteristics
06/12/2008CA2671632A1 Novel protein kinase modulators and therapeutic uses thereof
06/11/2008CN100394308C Organophotoreceptor with charge transport material having bis(9-fluorenone) azine groups
06/11/2008CN100393309C Use of alpha-phenylthiocarboxylic and alpha-phenyloxycarboxylic acids with serum-glucose-lowering and serum-lipid-lowering activity
06/10/2008US7385084 Compounds are significantly cytotoxic, show unexpectedly high water solubility and bioavailability and are effective when used in combination with other anticancer drugs like paclitaxel or its analogs;Lithium; 2-(N'-methyl-N'-thiobenzoyl-hydrazinocarbonyl)-1-(methyl-thiobenzoyl-hydrazono)-ethanolate
06/05/2008US20080132706 Compounds as PDE IV and TNF Inhibitors
06/05/2008CA2670626A1 Biosynthetic pathway and genes required for tropodithietic acid biosynthesis in silicibacter tm1040
06/04/2008EP1339669B1 N-alkylated gaba compounds, processes for their preparation and their use as medicaments
06/03/2008US7381842 For resist applications; thermostability, storage stability; color filters
06/03/2008US7381749 Sulfonamides as inhibitors of histone deacetylase for the treatment of disease
05/2008
05/27/2008US7378437 Use for the diabetes treatment of compounds or salts thereof, having the following general formula (I): A-(B)b0-(C)c0-NO2 wherein A contains the radical of a drug having an antiiflammatory or analgesic activity, B is a bivalen: linking
05/27/2008US7378412 Pharmaceutical compounds
05/21/2008EP1395551B1 Hydroxy alkyl amine derivatives as beta-secretase inhibitors and their use for the treatment of alzheimer's disease and similar diseases
05/20/2008US7375135 Fatty acid derivatives; preparation and uses thereof
05/20/2008CA2169695C Substituted benzenesulfonylureas and -thioureas, processes for their preparation, their use for the production of pharmaceutical preparations and medicaments containing them
05/20/2008CA2169694C Substituted benzenesulfonylureas and -thioureas, processes for their preparation, their use as a medicament or diagnostic, and medicament containing them
05/15/2008WO2008033494A3 Purification of bis(thiohydrazide amides)
05/13/2008US7371867 Non-racemic trifluoroleucine, and methods of making and using
05/08/2008WO2008024302A8 Compounds for treating proliferative disorders
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 ... 55